DK1112097T3 - Ny fremgangsmåde til fremstilling af substanser til overflademodificering - Google Patents

Ny fremgangsmåde til fremstilling af substanser til overflademodificering

Info

Publication number
DK1112097T3
DK1112097T3 DK99944936T DK99944936T DK1112097T3 DK 1112097 T3 DK1112097 T3 DK 1112097T3 DK 99944936 T DK99944936 T DK 99944936T DK 99944936 T DK99944936 T DK 99944936T DK 1112097 T3 DK1112097 T3 DK 1112097T3
Authority
DK
Denmark
Prior art keywords
surface modification
new method
preparing substances
preparing
heparin
Prior art date
Application number
DK99944936T
Other languages
Danish (da)
English (en)
Inventor
Elisabeth Scholander
Original Assignee
Carmeda Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmeda Ab filed Critical Carmeda Ab
Application granted granted Critical
Publication of DK1112097T3 publication Critical patent/DK1112097T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A61L33/0029—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate using an intermediate layer of polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99944936T 1998-09-09 1999-09-08 Ny fremgangsmåde til fremstilling af substanser til overflademodificering DK1112097T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO984143A NO984143L (no) 1998-09-09 1998-09-09 Ny prosess for å fremstille overflatemodifiserende stoffer
PCT/NO1999/000277 WO2000013718A1 (fr) 1998-09-09 1999-09-08 Nouveau procede de preparation de substances de modification de surfaces

Publications (1)

Publication Number Publication Date
DK1112097T3 true DK1112097T3 (da) 2003-10-20

Family

ID=19902393

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99944936T DK1112097T3 (da) 1998-09-09 1999-09-08 Ny fremgangsmåde til fremstilling af substanser til overflademodificering

Country Status (14)

Country Link
US (1) US6461665B1 (fr)
EP (1) EP1112097B1 (fr)
JP (1) JP4152075B2 (fr)
KR (1) KR100669132B1 (fr)
AT (1) ATE243538T1 (fr)
AU (1) AU757913B2 (fr)
BR (1) BR9913516B1 (fr)
CA (1) CA2342991C (fr)
DE (1) DE69909104T2 (fr)
DK (1) DK1112097T3 (fr)
ES (1) ES2203177T3 (fr)
NO (1) NO984143L (fr)
PT (1) PT1112097E (fr)
WO (1) WO2000013718A1 (fr)

Families Citing this family (97)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254564B1 (en) 1998-09-10 2001-07-03 Percardia, Inc. Left ventricular conduit with blood vessel graft
SE515295C2 (sv) * 1999-11-23 2001-07-09 Medicarb Ab Förfarande för framställning av konjugat av en biologiskt aktiv polysackarid och ett fast substrat, samt sådana konjugat
ATE414486T1 (de) * 2002-05-10 2008-12-15 Salviac Ltd System zum filtern von emboli
US6926965B2 (en) * 2002-09-11 2005-08-09 Novartis Ag LbL-coated medical device and method for making the same
US8071569B2 (en) * 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
WO2005115490A2 (fr) * 2004-05-25 2005-12-08 Surmodics, Inc. Procede et reactif destines a preparer des revetements contenant des molecules biologiques
US20060159650A1 (en) * 2005-01-14 2006-07-20 Bacterin, Inc. Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer
DE102005003632A1 (de) 2005-01-20 2006-08-17 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Katheter für die transvaskuläre Implantation von Herzklappenprothesen
ES2608399T3 (es) 2005-12-13 2017-04-10 Exthera Medical Corporation Método para la eliminación extracorpórea de un microbio patógeno, una célula inflamatoria o una proteína inflamatoria de la sangre
US8986713B2 (en) * 2006-05-12 2015-03-24 W. L. Gore & Associates, Inc. Medical device capable of being compacted and expanded having anti-thrombin III binding activity
US9114194B2 (en) * 2006-05-12 2015-08-25 W. L. Gore & Associates, Inc. Immobilized biologically active entities having high biological activity following mechanical manipulation
US8496953B2 (en) * 2006-05-12 2013-07-30 W. L. Gore & Associates, Inc. Immobilized biologically active entities having a high degree of biological activity following sterilization
US8021677B2 (en) * 2006-05-12 2011-09-20 Gore Enterprise Holdings, Inc. Immobilized biologically active entities having a high degree of biological activity
WO2008032758A1 (fr) 2006-09-15 2008-03-20 Toray Industries, Inc. Substrat et procédé pour la production de celui-ci
US20080200421A1 (en) 2007-02-21 2008-08-21 Zhao Jonathon Z Coating for a medical device having an anti-thrombotic conjugate
US20090281059A1 (en) * 2007-02-21 2009-11-12 Robert Falotico Coating for a medical device having an anti-thrombotic conjugate
US9693841B2 (en) 2007-04-02 2017-07-04 Ension, Inc. Surface treated staples, sutures and dental floss and methods of manufacturing the same
US8114465B2 (en) 2007-04-02 2012-02-14 Ension, Inc. Process for preparing a substrate coated with a biomolecule
US7896915B2 (en) 2007-04-13 2011-03-01 Jenavalve Technology, Inc. Medical device for treating a heart valve insufficiency
US8383156B2 (en) 2007-04-30 2013-02-26 Cordis Corporation Coating for a medical device having an anti-thrombotic conjugate
CA2690401C (fr) * 2007-06-18 2016-10-18 Olle Larm Dispositif et procede de restauration de la condition sanguine
WO2008155683A1 (fr) 2007-06-18 2008-12-24 Firmenich Sa Compositions agissant contre les mauvaises odeurs et leur procédé d'utilisation
US20090018646A1 (en) * 2007-07-10 2009-01-15 Zhao Jonathon Z Coating Employing an Anti-Thrombotic Conjugate
US20090192079A1 (en) * 2007-10-09 2009-07-30 Genzyme Corporation Prolonged delivery of heparin-binding growth factors from heparin-derivatized collagen
ES2903231T3 (es) 2008-02-26 2022-03-31 Jenavalve Tech Inc Stent para el posicionamiento y anclaje de una prótesis valvular en un sitio de implantación en el corazón de un paciente
US9044318B2 (en) 2008-02-26 2015-06-02 Jenavalve Technology Gmbh Stent for the positioning and anchoring of a valvular prosthesis
GB0816783D0 (en) * 2008-09-15 2008-10-22 Carmeda Ab Immobilised biological entities
US7819914B2 (en) 2008-12-16 2010-10-26 Cordis Corporation Adhesion promoting primer for coated surfaces
US20100161039A1 (en) * 2008-12-23 2010-06-24 Vipul Dave Adhesion promoting temporary mask for coated surfaces
AU2010200316A1 (en) 2009-01-30 2010-08-19 Cordis Corporation Reservoir Eluting Stent
US8829071B2 (en) * 2009-02-21 2014-09-09 Sofradim Production Medical device with degradation-retarding coating
CA2753189A1 (fr) 2009-02-21 2010-08-26 Nadya Belcheva Dispositifs medicaux presentant des surfaces activees
US9139669B2 (en) 2009-03-24 2015-09-22 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products
US8658707B2 (en) 2009-03-24 2014-02-25 W. L. Gore & Associates, Inc. Expandable functional TFE copolymer fine powder, the expanded functional products obtained therefrom and reaction of the expanded products
US8591932B2 (en) * 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
CA2782311C (fr) 2009-12-01 2017-06-27 Robert S. Ward Procede d'elimination de cytokines du sang par des polysaccharides immobilises en surface
JP5673525B2 (ja) 2009-12-24 2015-02-18 東レ株式会社 抗血液凝固作用を有する親水性高分子化合物
GB201004101D0 (en) 2010-03-12 2010-04-28 Carmeda Ab Immobilised biological entities
JP2013526388A (ja) 2010-05-25 2013-06-24 イエナバルブ テクノロジー インク 人工心臓弁、及び人工心臓弁とステントを備える経カテーテル搬送体内プロテーゼ
US9839540B2 (en) 2011-01-14 2017-12-12 W. L. Gore & Associates, Inc. Stent
US10166128B2 (en) 2011-01-14 2019-01-01 W. L. Gore & Associates. Inc. Lattice
WO2012112724A1 (fr) 2011-02-15 2012-08-23 Exthera Medical, Llc Dispositifs et procédé d'élimination de toxines, de cytokines inflammatoires et de pathogènes à diffusion hématogène
US9415193B2 (en) 2011-03-04 2016-08-16 W. L. Gore & Associates, Inc. Eluting medical devices
US20120310210A1 (en) 2011-03-04 2012-12-06 Campbell Carey V Eluting medical devices
US9101696B2 (en) 2011-03-11 2015-08-11 W.L. Gore & Associates, Inc. Immobilised biological entities
TW201311774A (zh) 2011-06-23 2013-03-16 Toray Industries 具有抗血液凝固作用的疏水性高分子化合物
TW201309354A (zh) 2011-06-23 2013-03-01 Toray Industries 醫療材料
US9775933B2 (en) 2012-03-02 2017-10-03 W. L. Gore & Associates, Inc. Biocompatible surfaces and devices incorporating such surfaces
ES2647577T3 (es) 2012-06-13 2017-12-22 Exthera Medical Corporation Uso de heparina y carbohidratos para tratar el cáncer
US9283072B2 (en) 2012-07-25 2016-03-15 W. L. Gore & Associates, Inc. Everting transcatheter valve and methods
US10376360B2 (en) 2012-07-27 2019-08-13 W. L. Gore & Associates, Inc. Multi-frame prosthetic valve apparatus and methods
US9931193B2 (en) 2012-11-13 2018-04-03 W. L. Gore & Associates, Inc. Elastic stent graft
US9144492B2 (en) 2012-12-19 2015-09-29 W. L. Gore & Associates, Inc. Truncated leaflet for prosthetic heart valves, preformed valve
US9968443B2 (en) 2012-12-19 2018-05-15 W. L. Gore & Associates, Inc. Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet
US9101469B2 (en) 2012-12-19 2015-08-11 W. L. Gore & Associates, Inc. Prosthetic heart valve with leaflet shelving
EP3620218A1 (fr) 2013-06-24 2020-03-11 ExThera Medical Corporation Système de filtration de sang contenant un substrat revêtu de mannose
JP6563394B2 (ja) 2013-08-30 2019-08-21 イェーナヴァルヴ テクノロジー インコーポレイテッド 人工弁のための径方向に折り畳み自在のフレーム及び当該フレームを製造するための方法
CA2928866C (fr) 2013-11-08 2021-11-09 Exthera Medical Corporation Procedes pour diagnostiquer des maladies infectieuses a l'aide de milieux d'adsorption
KR20160058902A (ko) 2013-11-28 2016-05-25 도레이 카부시키가이샤 항혈전성 재료
CA2928629C (fr) 2013-11-28 2018-04-17 Toray Industries, Inc. Materiau antithrombotique
US10842918B2 (en) 2013-12-05 2020-11-24 W.L. Gore & Associates, Inc. Length extensible implantable device and methods for making such devices
EP3106128B1 (fr) 2014-02-12 2020-12-02 Toray Industries, Inc. Vaisseau sanguin artificiel
US11839698B2 (en) 2014-03-13 2023-12-12 W. L. Gore & Associates, Inc. Drug composition and coating
CA2946294C (fr) 2014-04-24 2023-03-21 Exthera Medical Corporation Procede d'elimination de bacteries dans le sang a l'aide d'un debit eleve
US9827094B2 (en) 2014-09-15 2017-11-28 W. L. Gore & Associates, Inc. Prosthetic heart valve with retention elements
KR20170060062A (ko) 2014-09-22 2017-05-31 엑스테라 메디컬 코퍼레이션 웨어러블 혈액관류 장치
EP4403138A3 (fr) 2015-05-01 2024-10-09 JenaValve Technology, Inc. Dispositif et procédé avec fréquence de stimulateur cardiaque réduite lors du remplacement de valvule cardiaque
EP3095509A1 (fr) 2015-05-18 2016-11-23 Defymed Membranes fonctionnalisées pour organes bioartificiels
US10561766B2 (en) 2015-09-15 2020-02-18 W. L. Gore & Associates, Inc. Drug composition and coating
US10786615B2 (en) 2016-03-02 2020-09-29 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
CA3021860C (fr) 2016-04-21 2021-06-08 W. L. Gore & Associates, Inc. Endoprotheses diametralement reglables, systemes et procedes associes
CN109475419B (zh) 2016-05-13 2021-11-09 耶拿阀门科技股份有限公司 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法
CN109790259B (zh) 2016-09-30 2021-12-07 东丽株式会社 共聚物和使用其的医疗材料
JP6863295B2 (ja) 2016-10-07 2021-04-21 東レ株式会社 筒状織物
EP3318294A1 (fr) 2016-11-08 2018-05-09 Defymed Kit d'administration in situ d'un composé d'intérêt
US11197754B2 (en) 2017-01-27 2021-12-14 Jenavalve Technology, Inc. Heart valve mimicry
KR20190130618A (ko) 2017-03-31 2019-11-22 도레이 카부시키가이샤 통 형상 구조체
AU2018334191B2 (en) 2017-09-12 2021-04-08 Edwards Lifesciences Corporation Leaflet frame attachment for prosthetic valves
CN115024861A (zh) 2017-09-27 2022-09-09 W.L.戈尔及同仁股份有限公司 具有机械联接的瓣叶的假体瓣膜
CA3072814C (fr) 2017-09-27 2023-01-03 W.L. Gore & Associates, Inc. Valvule prothetique a cadre extensible et systemes et procedes associes
CN111447890B (zh) 2017-10-13 2023-01-31 W.L.戈尔及同仁股份有限公司 叠套式假体瓣膜及递送系统
JP7052032B2 (ja) 2017-10-31 2022-04-11 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 組織内方成長を促進する医療用弁及び弁膜
US12053367B2 (en) 2018-01-30 2024-08-06 Toray Industries, Inc. Plain-weave fabric, method for manufacturing same, and stent graft
AU2019232163A1 (en) 2018-03-09 2020-09-03 Carmeda Ab Improvements to processes for immobilising biological entities
US20190275213A1 (en) 2018-03-09 2019-09-12 Carmeda Ab Immobilising biological entities
WO2020018697A1 (fr) 2018-07-18 2020-01-23 W. L. Gore & Associates, Inc. Système de déploiement de dispositif médical implantable
WO2020070258A1 (fr) 2018-10-03 2020-04-09 Carmeda Ab Entités biologiques immobilisées
US20200179663A1 (en) 2018-12-11 2020-06-11 W. L. Gore & Associates, Inc. Medical devices for shunts, occluders, fenestrations and related systems and methods
WO2020132671A1 (fr) 2018-12-21 2020-06-25 W. L. Gore & Associates, Inc. Dispositif médical implantable à débit sanguin réglable
WO2020158847A1 (fr) 2019-01-30 2020-08-06 東レ株式会社 Matériau de base médical pour dispositif cardiovasculaire à demeure
US11497601B2 (en) 2019-03-01 2022-11-15 W. L. Gore & Associates, Inc. Telescoping prosthetic valve with retention element
CN113825517A (zh) 2019-05-16 2021-12-21 艾克塞拉医疗公司 调节内皮糖萼结构的方法
JP2023501647A (ja) 2019-11-15 2023-01-18 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 左心耳デバイス及び方法
WO2022169449A1 (fr) 2020-02-04 2022-08-11 W. L. Gore & Associates, Inc. Canule d'entrée/sortie
EP3892259A1 (fr) 2020-04-09 2021-10-13 Defymed Membranes pour dispositifs médicaux
CA3179703A1 (fr) 2020-04-09 2021-10-14 Defymed Membranes pour dispositifs medicaux

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8200751L (sv) 1982-02-09 1983-08-10 Olle Larm Forfarande for kovalent koppling for framstellning av konjugat och hervid erhallna produkter
US4600652A (en) 1985-04-01 1986-07-15 Warner-Lambert Company Permanently bonded antithrombogenic polyurethane surface
US5049403A (en) * 1989-10-12 1991-09-17 Horsk Hydro A.S. Process for the preparation of surface modified solid substrates
IT1260136B (it) 1992-04-17 1996-03-28 Alfa Wassermann Spa Glicosaminoglicani semisintetici contenenti acido alfa-l-galatturonicosostituito con radicali nucleofili in posizione 3
US5679659A (en) * 1995-08-22 1997-10-21 Medtronic, Inc. Method for making heparinized biomaterials
US6174326B1 (en) * 1996-09-25 2001-01-16 Terumo Kabushiki Kaisha Radiopaque, antithrombogenic stent and method for its production

Also Published As

Publication number Publication date
KR100669132B1 (ko) 2007-01-17
ATE243538T1 (de) 2003-07-15
CA2342991A1 (fr) 2000-03-16
ES2203177T3 (es) 2004-04-01
NO984143D0 (no) 1998-09-09
WO2000013718A1 (fr) 2000-03-16
US6461665B1 (en) 2002-10-08
DE69909104T2 (de) 2004-04-08
AU5765299A (en) 2000-03-27
NO984143L (no) 2000-03-10
DE69909104D1 (de) 2003-07-31
BR9913516B1 (pt) 2010-09-21
KR20010088799A (ko) 2001-09-28
JP2003507082A (ja) 2003-02-25
PT1112097E (pt) 2003-11-28
EP1112097B1 (fr) 2003-06-25
BR9913516A (pt) 2001-06-05
EP1112097A1 (fr) 2001-07-04
AU757913B2 (en) 2003-03-13
JP4152075B2 (ja) 2008-09-17
CA2342991C (fr) 2009-01-27

Similar Documents

Publication Publication Date Title
DK1112097T3 (da) Ny fremgangsmåde til fremstilling af substanser til overflademodificering
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
NO872602L (no) Elektrisk kontaktsett, sŸrlig for bruk under vann.
DE3671039D1 (de) Enzymatischer reinigungsmittelzusatz, reinigungsmittel und waschverfahren.
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
ES2153337T1 (es) Inhibidores de raf-quinasa.
NO872873D0 (no) Dispergent for behandling av olje paa vann.
DE58903736D1 (de) Verfahren zur behandlung von biomassen, z.b. klaerschlaemmen, guelle, usw.
NO863365D0 (no) Renseapparat for bruk under vann.
EA200000473A1 (ru) Состав модифицированного крахмала для удаления частиц из водных дисперсий
ATE484587T1 (de) Ldcam genannte moleküle
TR200101497T2 (tr) Lipolitik enzim varyantları
NO961604L (no) Ketogruppe-introduserende enzym, DNA som koder for samme, samt fremgangsmåte for fremstilling av ketokarotenoid
DK0888268T3 (da) Fremgangsmåde til cyclotrimerisering af alkyner i vandige opløsninger
DE3882078D1 (de) Amperometrische methode zur titration von nadh (1,4-dihydronicotinamid-adenine-dinucleotide) in loesung.
DE69530777D1 (de) Herstellung von Tee-Extrakt
NO861596L (no) Fremgangsmaate for behandling av vann, samt innretning for fremgangsmaatens utfoerelse.
FR2777189B1 (fr) Composition ophtalmique comprenant un beta-bloquant
DE3781453D1 (de) Waessrige zusammensetzung aus einem sulfonierten phenol, einem amin und einem gerbesalz, ihre herstellung und verwendung als gerbstoff.
FI872815A (fi) Luckpanel med foerbaettrad taetningsanordning, saerskilt anvaendbar i kontainertransportfartyg.
DE69911644D1 (de) Verfahren zur entwässerung organischer flüssigkeiten
DE3777656D1 (de) Mittel zur behandlung von alopezien.
EA199900419A1 (ru) Способ получения солей гидроксиламмония
PT1082291E (pt) Processo quimico para a sintese estereosselectiva de r-(-)-carnitina
NO913281D0 (no) Vandig loesning, saerlig til rensing av hoeyfasthetsstaal.